Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00940927 · ClinicalTrials.gov registry record · Phase 4
Dose-response of Albuterol in Asthmatics
A Phase 4 study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT00940927 is a Phase 4 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 81 participants.
The verdict
NCT00940927, a Phase 4 study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the lung function response after increasing doses of albuterol (a bronchodilator) in children and adults with asthma.
Interventions
- DRUG albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 1993-07 |
| Est. Completion | 1994-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00940927
The ClinicalTrials.gov registry entry for NCT00940927 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which albuterol is the first listed.
NCT00940927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00940927 about?
NCT00940927 is a clinical study titled "Dose-response of Albuterol in Asthmatics". The purpose of this study was to determine the lung function response after increasing doses of albuterol (a bronchodilator) in children and adults with asthma.
What is the current status of trial NCT00940927?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 1993-07. Estimated completion is 1994-10.
What interventions are being tested in trial NCT00940927?
The interventions under investigation include: albuterol (DRUG).
Who is sponsoring clinical trial NCT00940927?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.